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OBJECTIVE—To determine the prevalence of prediabetes and diabetes among rural and
urban Malaysians.
RESEARCH DESIGN AND METHODS—This cross-sectional survey was conducted
among 3,879 Malaysian adults (1,335 men and 2,544 women). All subjects underwent the
75-g oral glucose tolerance test (OGTT).
RESULTS—The overall prevalence of prediabetes was 22.1% (30.2% in men and 69.8% in
women). Isolated impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) were
found in 3.4 and 16.1% of the study population, respectively, whereas 2.6% of the subjects had
both IFG and IGT. Based on an OGTT, the prevalence of newly diagnosed type 2 diabetes was
12.6% (31.0% in men and 69.0% in women). The prediabetic subjects also had an increased
prevalence of cardiovascular disease risk factors.
CONCLUSIONS—The large proportion of undiagnosed cases of prediabetes and diabetes
reﬂects the lack of public awareness of the disease.
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T
he prevalence of type 2 diabetes has
increased globally over the past two
decades. In Malaysia, the National
Health and Morbidity Survey (NHMS)
2006(Z.Hussein,W.M.W.B.,W.N.w.M.,
G.R. Letchuman, J. Hasan, F. Ismail, N.
Mohd Nor, G.H. Tee, and M.R. Ishak;
NHMS III Diabetes Study Group, unpub-
lished data) recorded a diabetes prevalence
of 14.9% among adults aged .30 years.
This is an astounding increase from a simi-
lar survey conducted in 1996. Despite this
risingprevalenceandincreasingawareness,
diabetes is often left undetected (1). Early
recognition and prevention is therefore im-
portant because diabetes is associated with
unhealthy contemporary lifestyle (2). Im-
paired glucose tolerance (IGT) and im-
paired fasting glucose (IFG) identify
individuals at increased risk for developing
diabetes and cardiovascular disease (CVD)
(3,4). Because of increased awareness, IGT
isbeingdiagnosedandreportedmorefre-
quently, resulting in the higher prev-
alence of IGT compared with a few
decades ago. Using the 75-g oral glucose
tolerance test (OGTT) would identify
those individuals with IGT and diabetes
based on 2-h postprandial blood glucose
values. The aim of this study was there-
fore to determine the prevalence of pre-
diabetes and diabetes using a 75-g OGTT
in both rural and urban areas in Malaysia
and to identify the metabolic abnormali-




sectional study was conducted from April
until August of 2008 among Malaysians
aged $18 years. The subjects were ran-
domly selected with the aid of the kirsch
tables and the topographical charts of the
district. Written consents were obtained.
Ethical approval for the study was ob-
tained from the medical research and
ethicscommitteeoftheMinistryofHealth,
Malaysia.
An OGTT and other biochemical
tests, as well as anthropometric measure-
ments, were performed. Blood samples
were processed onthe same day and trans-
ported to a central laboratory in the Insti-
tute for Medical Research, Kuala Lumpur,
and stored at 220°C prior to additional
analysis. Fasting plasma glucose; triglycer-
ides; and HDL, LDL, and total cholesterol
were analyzed using a Selectra XL chemis-
try analyzer. The interassay coefﬁcients of
variation for glucose at 6.27 and 15.6
mmol/L were 4.7 and 6.3%, respectively,
and for lipids ranged from 3.5 to 6.4%.
EpiData version 3.1 was used for data
entry, and data were then analyzed using
SPSS version 17. Data were expressed as
means 6 SD. Signiﬁcant results were de-
termined according to the two-tailed alter-
native hypothesis and deemed signiﬁcant
when the P value was , 0.05.
RESULTS—The prevalence of predia-
betes among adults was 22.1%, affecting
almost half (47.0%) of the adults aged
between 30 and 49 years. The prevalence
of isolated IGT was higher (16.1%) com-
pared with isolated IFG (3.4%) and the
combinationofbothIFGandIGT(2.6%).
Subjects with both IFG and IGT had
higherwaistcircumferenceandBMIcom-
paredwith those with isolated IFG orIGT
(Table 1).Among overweight adults (BMI
$23 kg/m
2) with prediabetes, 17.3% had
isolated IGT, 3.8% had isolated IFG, and
3.1% had both IFG and IGT. For those
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CVD risk factors was high (65.7% had
dyslipidaemia, 52.0% had hypertension,
76.5% had abdominal obesity [.90 cm
for men and .80 cm for women], 82.4%
hadBMI$23kg/m
2,and10.8%werecur-
rent smokers). Using multiple logistic re-
gression analysis, prediabetes was found
tobe associated witha history of smoking,
age, and the low-income group.
The prevalence of newly diagnosed
type2diabeteswas12.6%(31.0%inmen
and69.0%in women) andincreasedwith
age from 3.8% among adults aged ,30
years to 11.6% among adults aged 40–
49 years and was still higher (16.5%) in
theolderage-group($60years).Without
relying on the OGTT, we would have
missed ~5% of type 2 diabetes cases.
CONCLUSIONS—Glucose intoler-
ance in this study is deﬁned according
to the World Health Organization diag-
nostic criteria (5). The prevalence of pre-
diabetes in our study is comparable to
other similar studies (6,7), and the per-
c e n t a g er o s et o2 4 . 4 %i nt h o s ea g e d
$60 years. Interestingly, the prevalence
of IFG was lower than IGT in studied
populations. Similarly, IGT was found
to be more prevalent compared with
IFG in Mauritius (8), in the U.S. (9), and
in Pima Indians (10).
In our study, ~16.1% of adults had
isolated IGT, a condition that increases
the risk for diabetes and other cardiovas-
cular risk factors (11). In fact, many sub-
jects with IGT will develop CVD before
progressing to diabetes, as shown in one
Japanese study (12). Changes in lifestyle
and dietary habits in our population, in
both rural and in urban areas, have re-
sulted in the increased prevalence of risk
factors for CVD, such as obesity, hyper-
tension, and diabetes. Our prediabetic
subjects had a high risk for CVD. This is
not to be unexpected because prediabetes
is a prelude to type 2 diabetes and is also
associated with various comorbidities,
which has been termed metabolic syn-
drome.
The prevalence of newly diagnosed
type 2 diabetes in our study was 12.6%
and is increasing with age. This high
prevalence of undiagnosed diabetes, to-
gether with its earlier age of onset (,30
years),posesaseriouspublichealthprob-
lem, especially if there is no serious con-
certed effort taken to improve it. By
performing the OGTT, we were able to
diagnose more subjects with type 2 dia-
betes because it captured both fasting and
elevated 2-h plasma glucose levels.
In summary, the high prevalence of
glucose intolerance among adults aged
.18 years has raised public health con-
cerns. Because individuals with prediabe-
tes usually have no apparent clinical
symptoms, great efforts may be needed
to identify them early and to intervene
against the root causes of insulin resis-
tance, such as overweight, physical inac-
tivity, and unhealthy diet in pediatric
primary care and through public health
services.
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